BIOMAT Database Logo BIOMAT Database Logo

Pharmacokinetics of cimetidine in patients undergoing hemodialysis. 1983

P A Bjaeldager, and J B Jensen, and L P Nielsen, and N E Larsen, and E F Hvidberg

In order to establish improved guidelines for dosage adjustments of cimetidine before and during hemodialysis, the kinetics of this drug was investigated in 7 uremic patients undergoing regular hemodialysis. The absorption fraction was found to be 0.75 (range 0.61-0.86), the terminal half-life in plasma between 138 and 238 min, the total body clearance (Cltotal) between 178 and 337 ml/min, and the apparent volume of distribution about 1 l/kg. During hemodialysis no excess amounts of cimetidine were removed from serum. In 3 patients a weak rebound phenomenon was seen after hemodialysis. Based on the Cltotal obtained in this study, dosage schemes producing a 24-hours mean steady state concentration from 0.60 (2.38) to 1.20 (4.76) mg/l (mumol/l) are suggested.

UI MeSH Term Description Entries
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002927 Cimetidine A histamine congener, it competitively inhibits HISTAMINE binding to HISTAMINE H2 RECEPTORS. Cimetidine has a range of pharmacological actions. It inhibits GASTRIC ACID secretion, as well as PEPSIN and GASTRIN output. Altramet,Biomet,Biomet400,Cimetidine HCl,Cimetidine Hydrochloride,Eureceptor,Histodil,N-Cyano-N'-methyl-N''-(2-(((5-methyl-1H-imidazol-4-yl)methyl)thio)ethyl)guanidine,SK&F-92334,SKF-92334,Tagamet,HCl, Cimetidine,Hydrochloride, Cimetidine,SK&F 92334,SK&F92334,SKF 92334,SKF92334
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005260 Female Females
D006146 Guanidines A family of iminourea derivatives. The parent compound has been isolated from mushrooms, corn germ, rice hulls, mussels, earthworms, and turnip juice. Derivatives may have antiviral and antifungal properties.
D006435 Renal Dialysis Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION. Dialysis, Extracorporeal,Dialysis, Renal,Extracorporeal Dialysis,Hemodialysis,Dialyses, Extracorporeal,Dialyses, Renal,Extracorporeal Dialyses,Hemodialyses,Renal Dialyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

P A Bjaeldager, and J B Jensen, and L P Nielsen, and N E Larsen, and E F Hvidberg
Pharmacokinetics of ceftizoxime in patients undergoing hemodialysis.
January 1982, Methods and findings in experimental and clinical pharmacology,
P A Bjaeldager, and J B Jensen, and L P Nielsen, and N E Larsen, and E F Hvidberg
Pharmacokinetics of cefamandole in patients undergoing hemodialysis.
September 1979, International journal of clinical pharmacology and biopharmacy,
P A Bjaeldager, and J B Jensen, and L P Nielsen, and N E Larsen, and E F Hvidberg
[Pharmacokinetics of cefodizime in patients undergoing hemodialysis].
December 1991, The Japanese journal of antibiotics,
P A Bjaeldager, and J B Jensen, and L P Nielsen, and N E Larsen, and E F Hvidberg
Pharmacokinetics of cefoxitin in patients undergoing hemodialysis.
August 1979, International journal of clinical pharmacology and biopharmacy,
P A Bjaeldager, and J B Jensen, and L P Nielsen, and N E Larsen, and E F Hvidberg
Pharmacokinetics of ritanserin in patients undergoing hemodialysis.
July 1991, Journal of clinical pharmacology,
P A Bjaeldager, and J B Jensen, and L P Nielsen, and N E Larsen, and E F Hvidberg
Netilmicin pharmacokinetics in uremic patients undergoing hemodialysis.
October 1986, Chemioterapia : international journal of the Mediterranean Society of Chemotherapy,
P A Bjaeldager, and J B Jensen, and L P Nielsen, and N E Larsen, and E F Hvidberg
Garenoxacin pharmacokinetics in patients undergoing maintenance hemodialysis.
April 2017, Hemodialysis international. International Symposium on Home Hemodialysis,
P A Bjaeldager, and J B Jensen, and L P Nielsen, and N E Larsen, and E F Hvidberg
[Pharmacokinetics of defibrotide in uremic patients undergoing hemodialysis].
December 1991, Minerva medica,
P A Bjaeldager, and J B Jensen, and L P Nielsen, and N E Larsen, and E F Hvidberg
Pharmacokinetics and dialysability of naltrexone in patients undergoing hemodialysis.
January 2004, European journal of drug metabolism and pharmacokinetics,
P A Bjaeldager, and J B Jensen, and L P Nielsen, and N E Larsen, and E F Hvidberg
Pharmacokinetics of digoxin and digitoxin in patients undergoing hemodialysis.
April 1975, The American journal of medicine,
Copied contents to your clipboard!